Evidence map›Paper›PMID 28508381›Full record

ReviewJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2017

Visualization of metallodrugs in single cells by secondary ion mass spectrometry imaging.

Kui Wu, Feifei Jia, Wei Zheng, Qun Luo, Yao Zhao, Fuyi Wang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Direct Cell Radiolabeling forChemical reviews · 2022
    Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kui WuBeijing National Laboratory for Molecular Sciences, Beijing, 100190, People's Republic of China.
Feifei JiaBeijing National Laboratory for Molecular Sciences, Beijing, 100190, People's Republic of China.
Wei ZhengBeijing National Laboratory for Molecular Sciences, Beijing, 100190, People's Republic of China.
Qun LuoBeijing National Laboratory for Molecular Sciences, Beijing, 100190, People's Republic of China.
Yao ZhaoBeijing National Laboratory for Molecular Sciences, Beijing, 100190, People's Republic of China.
Fuyi WangBeijing National Laboratory for Molecular Sciences, Beijing, 100190, People's Republic of China. fuyi.wang@iccas.ac.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secondary ion mass spectrometry, including nanoscale secondary ion mass spectrometry (NanoSIMS) and time-of-flight secondary ion mass spectrometry (ToF-SIMS), has emerged as a powerful tool for biological imaging, especially for single cell imaging. SIMS imaging can provide information on subcellular distribution of endogenous and exogenous chemicals, including metallodrugs, from membrane through to cytoplasm and nucleus without labeling, and with high spatial resolution and chemical specificity. In this mini-review, we summarize recent progress in the field of SIMS imaging, particularly in the characterization of the subcellular distribution of metallodrugs. We anticipate that the SIMS imaging method will be widely applied to visualize subcellular distributions of drugs and drug candidates in single cells, exerting significant influence on early drug evaluation and metabolism in medicinal and pharmaceutical chemistry. Recent progress of SIMS applications in characterizing the subcellular distributions of metallodrugs was summarized.

Indexed as

Single-Cell AnalysisSpectrometry, Mass, Secondary IonAntineoplastic AgentsCell ProliferationHumansOrganometallic CompoundsAntineoplastic AgentsOrganometallic CompoundsMass spectrometry imagingMetallodrugSecondary ion mass spectrometrySingle cellVisualization

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.